Lorlatinib-containing medicinal products 2026
Original notice title
Czechia – Antineoplastic and immunomodulating agents – LP s obsahem lorlatinibu 2026
Opportunity Score
Why this score?
Opportunity
71 / 100
Complexity
34 / 100
Risk factors
The tender requires electronic submission and the deadline is specific; missing the deadline or using the wrong channel...
Tie bids are resolved by drawing lots, which adds uncertainty even when pricing is competitive.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- CZK 20M estimated value
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Repeated deliveries of medicinal products containing lorlatinib.
- Supply contract for antineoplastic and immunomodulating agents.
Show full summary
Open supply tender by Fakultní nemocnice Olomouc for repeated deliveries of lorlatinib-containing medicinal products in Czechia (CZ071/Olomouc region). One lot is stated, with an estimated value of CZK 20,006,514 and a 36-month duration. Submission is electronic and the deadline is 2026-08-05 08:00 UTC (10:00 local time in the XML notice). Award is by lowest price only.
Risks
The tender requires electronic submission and the deadline is specific; missing the deadline or using the wrong channel...
Tie bids are resolved by drawing lots, which adds uncertainty even when pricing is competitive.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Only one lot is provided in the structured data.
- Contract duration is 36 months.
Administrative
- Electronic submission is required.
Award Criteria
Lot 1
Buyer
Location
Olomouc - Nová Ulice, CZE
Website
Buyer profile
Identifier
00098892
Activity
Health
Lots (1)
LOT-0001
Lorlatinib-containing medicinal products 2026
Repeated supply of medicinal products containing the active substance lorlatinib. The lot is for supplies in Czechia, specifically the CZ071 region. The lot data comes from structured data and the XML notice.
EUR 824.9k
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Zadavatel bude hodnotit v souladu s § 114 odst. 2 ZZVZ ekonomickou výhodnost nabídek podle nejnižší nabídkové ceny v Kč bez DPH, která bude převzata z vyplněného krycího listu nabídkové ceny. V případě rovnosti nejnižších celkových nabídkových cen v Kč bez DPH několika účastníků rozhodne o výběru nejvýhodnější nabídky los. Účastníci, kteří podali shodnou nejnižší celkovou nabídkovou cenu, budou zadavatelem písemně vyzváni k osobní účasti na losování. Hodnotící komise posoudí nabídky podle ust. § 113 ZZVZ (mimořádně nízká nabídková cena).
Value note
Show original TED data
Original lot title
LP s obsahem lorlatinibu 2026
Original TED description
Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků s obsahem účinné látky lorlatinib
Procurement Details
- Publication date
- 01 Jul 2026
- Languages
- Czech
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 454382-2026
Documents (1)
Similar tenders
Opportunity Score
Why this score?
Opportunity
71 / 100
Complexity
34 / 100
Risk factors
The tender requires electronic submission and the deadline is specific; missing the deadline or using the wrong channel...
Tie bids are resolved by drawing lots, which adds uncertainty even when pricing is competitive.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications